α7 nAChR-dependent activation of glial cells is observed [17] and α7 nAChR agonists are able to preserve nervous tissue in neuropathic states [17, 42] as well as in neurodegenerative conditions such as Parkinson's and Alzheimer's diseases [43]. Here, CHRNA7 is linked to Parkinson disease.